USD
+$0.00
(+0.00%
)At Close (As of Sep 15, 2025)
$67.09M
Market Cap
-
P/E Ratio
-0.25
EPS
$5.48
52 Week High
$0.40
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $509K |
Total Revenue | $510K |
Cost Of Revenue | $763 |
Costof Goods And Services Sold | $763 |
Operating Income | -$4.7M |
Selling General And Administrative | $5M |
Research And Development | $179K |
Operating Expenses | $5.2M |
Investment Income Net | - |
Net Interest Income | -$739K |
Interest Income | $87K |
Interest Expense | $826K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $201K |
Income Before Tax | -$5.4M |
Income Tax Expense | -$111K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$5.3M |
Comprehensive Income Net Of Tax | - |
Ebit | -$4.5M |
Ebitda | -$4.3M |
Net Income | -$4.9M |
Field | Value (USD) |
---|---|
Total Assets | $7.5M |
Total Current Assets | $2.2M |
Cash And Cash Equivalents At Carrying Value | $248K |
Cash And Short Term Investments | $248K |
Inventory | - |
Current Net Receivables | $1.2M |
Total Non Current Assets | $5.4M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | $2.3M |
Short Term Investments | $65K |
Other Current Assets | $712K |
Other Non Current Assets | - |
Total Liabilities | $6.8M |
Total Current Liabilities | $6.6M |
Current Accounts Payable | - |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $3M |
Total Non Current Liabilities | $258K |
Capital Lease Obligations | $640K |
Long Term Debt | - |
Current Long Term Debt | $1.8M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $3.2M |
Other Current Liabilities | $3.5M |
Other Non Current Liabilities | $22K |
Total Shareholder Equity | $1.2M |
Treasury Stock | - |
Retained Earnings | -$69M |
Common Stock | $14K |
Common Stock Shares Outstanding | $12M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$1.8M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $201K |
Capital Expenditures | $0 |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | - |
Cashflow From Financing | $2M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | -$7.3K |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$5.3M |
Field | Value (USD) |
---|---|
Gross Profit | $509K |
Total Revenue | $510K |
Cost Of Revenue | $763 |
Costof Goods And Services Sold | $763 |
Operating Income | -$4.7M |
Selling General And Administrative | $5M |
Research And Development | $179K |
Operating Expenses | $5.2M |
Investment Income Net | - |
Net Interest Income | -$739K |
Interest Income | $87K |
Interest Expense | $826K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $201K |
Income Before Tax | -$5.4M |
Income Tax Expense | -$111K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$5.3M |
Comprehensive Income Net Of Tax | - |
Ebit | -$4.5M |
Ebitda | -$4.3M |
Net Income | -$4.9M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
American BriVision (Holding) Corporation, a clinical-stage biopharmaceutical company, develops drugs and medical devices to meet unmet medical needs in the United States.